HIV-1 tat Protein (1-9)

HIV-1 tat Protein (1-9) occurs extracellularly and has a role in the immunosuppression of non-HIV-1-infected T cells in acquired AIDS. HIV-1 tat Protein (1-9) is an inhibitor of DP IV. HIV-1 tat Protein (1-9) can be synthesized by phase peptide synthesis with Fmoc (N- (9-fluorenyl) methoxycarbonyl) technique using the peptide synthesizer 431A. HIV-1 tat Protein (1-9) can be studied in research on HIV-1[1].

Product Specifications

CAS Number

[200203-20-9]

UNSPSC

12352209

Target

HIV

Related Pathways

Anti-infection

Field of Research

Infection; Inflammation/Immunology

Smiles

O=C(N[C@@H](CC(O)=O)C(N1[C@@H](CCC1)C(N[C@@H](C(C)C)C(N[C@@H](CC(O)=O)C(N2[C@@H](CCC2)C(N[C@@H](CC(N)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCSC)N

Molecular Formula

C43H68N10O17S

Molecular Weight

1029.12

References & Citations

[1]Wrenger, S., et al., (1997) . The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth. The Journal of biological chemistry, 272 (48), 30283–30288.